Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
Clinical trial NCT05079282 · RECRUITING
Trial details
- NCT number
- NCT05079282
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-10
- Primary completion
- 2027-08-31
- Enrollment
- 217
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.